News
In response to FDA safety review of mifepristone, 4 pro-choice states hit back
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-abortion states have fired back, filing (PDF) a petition asking the U.S. regulator to lift restrictions on the treatment.
Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...
The following is the transcript of an interview with FDA commissioner Dr. Marty Makary that aired on "Face the Nation with ...
FOX News on MSN3d
Dr. Makary responds after tense exchange with CBS’ Margaret BrennanFDA Commissioner Dr. Marty Makary discusses vaccine safety for children, baby formula nutrition and more on ‘The Brian ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the ...
FDA Commissioner Dr. Marty Makary discusses baby formula nutrition and broader efforts to ‘make America healthy again’ on ...
Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent ...
The FDA rolled out its agency-wide AI tool weeks ahead of schedule, on Monday offering a look at the technology and how it ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback